Capital & Planning »

Vertex Pharmaceuticals Incorporated shares owned by Capital & Planning

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Capital & Planning from 13F filings

Historical chart of Capital & Planning investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Capital & Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Capital & Planning

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2k 5 446.60
2024-12-31 $2.0k 5 402.80

More positions owned by Capital & Planning

Alphabet Common Stock (GOOGL)
Amazon Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Southern Company Common Stock (SO)
Visa Common Stock (V)
Eli Lilly Common Stock (LLY)
Duke Energy Common Stock (DUK)
Apple Common Stock (AAPL)
Mcdonalds Corp Common Stock (MCD)
Caterpillar Common Stock (CAT)
Church & Dwight Common Stock (CHD)
Nvidia Corp Common Stock (NVDA)
Procter & Gamble Common Stock (PG)
Texas Instruments Common Stock (TXN)
Meta Platforms Common Stock (META)

View all positions for Capital & Planning

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas
Bank of America Corporation
Jennison Associates

View all funds holding Vertex Pharmaceuticals Incorporated